header EO Care image

Expert, Cannabinoid-Based Cancer Symptom Management

Cancer symptom management that lowers costs and improves outcomes using clinically proven cannabinoid protocols.

Description

EO is the leader in cannabinoid-based symptom management. Our personalized care plans provide evidence-based product, dose, and use recommendations based on the employee’s cancer and treatment related symptoms, medical and cannabis use history, current medications, and ongoing feedback. And our supportive oncologist-led team can be messaged anytime as questions arise.

All recommended products are federally legal, clinician-designed, organic, 3rd-party tested and ship right to the home - without the need for medical cards or dispensaries.

A unique clinical guidance engine drives the EO experience, powered by individual employee inputs and feedback, thousands of anonymized patient records, validated research and clinical safety rules. This guidance engine was born and evolved in supportive oncology settings at leading, NCI-designated cancer centers.

For employers, our approach to care means fewer avoidable ER visits and hospitalizations, reduced reliance on opioids and high-cost prescriptions - and the opportunity to provide unique and vital support to your employees across their entire cancer treatment and survivorship journey.

By The Numbers

  • $12,000 Estimated reduction in annual per-patient cancer symptom management costs.
  • ~52% lower - Annual per-patient cancer symptom management cost.
  • 92% Of those seeking help for cancer-related nausea and appetite-related symptoms find significant relief. 
  • 74% Of those seeking relief for cancer-related pain, stress or sleep concerns find significant relief. 
  • 2x-10x Less likely to cause negative side effects compared to commonly prescribed cancer symptom management drugs.
  • 90 Our net promoter score for those managing cancer and treatment-related symptoms. (A score of 50 is considered exceptional).

Features

Care Plan Creation & Management

Our personalized care plans provide clinically-validated cannabinoid product, dose and use guidance based on an employee’s cancer-related symptoms (e.g. nausea, appetite loss, pain, stress and sleep issues), medical and cannabis use history, medications in use, daily schedule and ongoing feedback. As their symptoms and health evolves, so does their plan.

Ongoing, Clinician-Led Support

Whenever an employee has questions or concerns about their plan and how to use cannabinoids most safely and effectively, they can message or call our clinician-led team. The team is overseen by Dr. Brooke Worster, EO Chief Medical Officer and Director, Supportive Oncology at the Sidney Kimmel Cancer Center in Philadelphia.

Care Team Reporting

As desired, detailed progress reports can be provided to the employee’s oncologist, other relevant clinicians and/or caregivers. These reports can provide a useful window into the employee’s symptom intensity and duration, side-effect profile (if any), overall well-being and quality of life.

Media

Integration Diagram

Data

Rewards

Rewards

EO Care
EO Care
Data

Rewardable activities

Rewardable activities

Reviews

Write your own review